|本期目录/Table of Contents|

[1]张爱斌,程晓龙,刘敏,等.血脂异常与胃癌发生关系的研究进展[J].医学研究与战创伤救治(原医学研究生学报),2022,24(5):509-513.[doi:10.3969/j.issn.1672-271X.2022.05.013]
　ZHANG Ai-bin,CHENG Xiao-long,LIU Min,et al.Research progress on the relationship between dyslipidemia and gastric cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(5):509-513.[doi:10.3969/j.issn.1672-271X.2022.05.013]
点击复制

血脂异常与胃癌发生关系的研究进展()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第24卷
期数:
2022年5期
页码:
509-513
栏目:
综述
出版日期:
2022-11-02

文章信息/Info

Title:
Research progress on the relationship between dyslipidemia and gastric cancer
作者:
张爱斌; 程晓龙; 刘敏; 陈兆峰
作者单位：730000兰州,兰州大学第一临床医学院（张爱斌、程晓龙）；730000兰州,兰州大学第一医院消化科（刘敏、陈兆峰）
Author(s):
ZHANG Ai-bin1;  CHENG Xiao-long1 ;  LIU Min2;  CHEN Zhao-feng2
(1.The First School of Clinical Medicine, Lanzhou University, Lanzhou 730000, Gansu, China; 2. Department of Gastroenterology,The First Hospital of Lanzhou University, Lanzhou 730000, Gansu, China）
关键词:
血脂异常; 胃癌; 调脂药物
Keywords:
dyslipidemia;  gastric cancer;  lipid-regulating agents
分类号:
R573
DOI:
10.3969/j.issn.1672-271X.2022.05.013
文献标志码:
A
摘要:
随着饮食习惯的改变，血脂紊乱发生率亦显著上升。血脂异常不仅作为一系列代谢性疾病的特征性表现，同时其亦是包括胃癌在内的多种疾病的重要危险因素。多数癌症患者中常存在血脂异常的情况，而脂质代谢水平的紊乱可能伴随着更高的肿瘤发病风险，因此合理使用降脂药物对于血脂异常本身甚至癌症的预防均有一定的作用。文章回顾和分析了当前有关血脂异常和胃癌发生的相关研究，主要就血脂异常和其可能的致癌机制、与胃癌发病的相关性以及调脂药物在胃癌患者中的应用进展进行综述。
Abstract:
The incidence of dyslipidemia has been increasing significantly as the change of dietary habits. Dyslipidemia serves as a hallmark manifestation of a range of metabolic diseases and an important risk factor for a variety of diseases such as stomach cancer. Dyslipidemia occurs in many of cancers, whereas the disturbance of lipid metabolism level may be associated with a higher risk of tumorigenesis. Consequently, the appropriate use of lipid-lowering agents may potentially play a role in the prevention of dyslipidemia and possibly even cancer. In this review, we analyzed the current studies on dyslipidemia and gastric carcinogenesis, with the aim of elucidating dyslipidemia and possible carcinogenic mechanisms, the correlation with gastric carcinogenesis, and the application of lipid-regulating agents in the patients with gastric cancer.

参考文献/References:

[1]中国抗癌协会整合肿瘤心脏病学分会专家组.恶性肿瘤患者血脂管理中国专家共识[J].中华肿瘤杂志, 2021, 43(10): 1043-1053.
[2]Long J, Zhang CJ, Zhu N, et al. Lipid metabolism and carcinogenesis, cancer development[J].Am J Cancer Res, 2018, 8(5): 778.
[3]Lin CF, Chang YH, Chien SC, et al. Epidemiology of dyslipidemia in the Asia Pacific region[J].Int J Gerontol, 2018, 12(1): 2-6.
[4]Liu X, Yu S, Mao Z, et al. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study[J].Lipids Health Dis, 2018, 17(1): 1-12.
[5]Wang M, Liu M, Li F, et al. Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle age rural Chinese[J].Lipids Health Dis, 2020, 19(1): 1-11.
[6]Song P, Zha M, Yang X, et al. Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older Chinese[J].Atherosclerosis, 2019, 282: 57-66.
[7]Xi Y, Niu L, Cao N, et al. Prevalence of dyslipidemia and associated risk factors among adults aged≥ 35 years in northern China: a cross-sectional study[J]. BMC Public Health, 2020, 20(1): 1-9.
[8]Casares D, Escribá PV, Rosselló CA. Membrane lipid composition: Effect on membrane and organelle structure, function and compartmentalization and therapeutic avenues[J].Int J Mol Sci, 2019, 20(9): 2167.
[9]Liu W, Chakraborty B, Safi R, et al. Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer[J]. Nat Commun, 2021, 12(1): 1-15.
[10]Rodriguez-Garcia M, Alcaide P. Vascular inflammation and hyperlipidemia: the neutrophil within[J].JACC Basic Transl Sci, 2021, 6(6): 524-526.
[11]Xu S, Chaudhary O, Rodríguez-Morales P, et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors[J]. Immunity, 2021, 54(7): 1561-1577.
[12]中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中华全科医师杂志,2017,16(1):15-35.
[13]Michels N, van Aart C, Morisse J, et al. Chronic inflammation towards cancer incidence: A systematic review and meta-analysis of epidemiological studies[J].Crit Rev Oncol Hematol, 2021, 157: 103177.
[14]He Y, Wang Y, Luan F, et al. Chinese and global burdens of gastric cancer from 1990 to 2019[J].Cancer Med, 2021, 10(10): 3461-3473.
[15]Wu Y, Xin J, Loehrer EA, et al. High-density lipoprotein, low-density lipoprotein and triglyceride levels and upper gastrointestinal cancers risk: a trans-ancestry Mendelian randomization study[J].Eur J Clin Nutr, 2022, 76(7): 995-1002.
[16]Zou Y, Wu L, Yang Y, et al. Serum lipid levels correlate to the progression of gastric cancer with neuroendocrine immunophenotypes: A multicenter retrospective study[J].Transl Oncol, 2021, 14(1): 100925.
[17]Cui P, Huang C, Guo J, et al. Metabolic profiling of tumors, sera, and skeletal muscles from an orthotopic murine model of gastric cancer associated-cachexia[J].J Proteome Res, 2019, 18(4): 1880-1892.
[18]Pih GY, Gong EJ, Choi JY, et al. Associations of serum lipid level with gastric cancer risk, pathology, and prognosis[J].Cancer Res Treat, 2021, 53(2): 445-456.
[19]Shen JG, Jin LD, Dong MJ, et al. Low level of serum high-density lipoprotein cholesterol in gastric cancer correlates with cancer progression but not survival[J].Transl Cancer Res, 2020, 9(10): 6206-6213.
[20]Kitayama J, Hatano K, Kaisaki S, et al. Hyperlipidaemia is positively correlated with lymph node metastasis in men with early gastric cancer[J].Br J Surg, 2004, 91(2): 191-198.
[21]Ma C, Xie J, Luo C, et al. OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGFC expression and secretion[J]. Int J Oncol, 2019, 54(2): 572-584.
[22]Wang S, Yao Y, Rao C, et al. 25-HC decreases the sensitivity of human gastric cancer cells to 5-fluorouracil and promotes cells invasion via theTLR2/NF-κB signaling pathway[J]. Int J Oncol, 2019, 54(3): 966-980.
[23]Lim JH, Shin CM, Han K, et al. Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women[J]. Gastric Cancer, 2022, 25(1): 11-21.
[24]Chen L, Peng J, Wang Y, et al. Fenofibrate-induced mitochondrial dysfunction and metabolic reprogramming reversal: the anti-tumor effects in gastric carcinoma cells mediated by the PPAR pathway[J].Am J Transl Res, 2020, 12(2): 428-446.
[25]Ma Z, Wang W, Jin G, et al. Effect of statins on gastric cancer incidence: a meta-analysis of case control studies[J].J Cancer Res Ther, 2014, 10(4): 859-865.
[26]Kwon MJ, Kang HS, Kim JH, et al. Association between Statin Use and Gastric Cancer: A Nested Case-Control Study Using a National Health Screening Cohort in Korea[J].Pharmaceuticals, 2021, 14(12): 1283.
[27]Weltermann T, Schulz C, Macke L. Effect of frequently prescribed drugs on gastric cancer risk[J].Best Pract Res Clin Gastroenterol, 2021, 50-51: 101741.
[28]Hong JY, Kim HJ, Kim K, et al. TPK1 as a predictive marker for the anti-tumour effects of simvastatin in gastric cancer[J].Pathol Res Pract, 2020, 216(3): 152820.
[29]Yu R, Longo J, van Leeuwen JE, et al. Statin-induced cancer cell death can be mechanistically uncoupled from prenylation of RAS family proteins[J].Cancer Res, 2018, 78(5): 1347-1357.
[30]Lin TY, Lan WH, Chiu YF, et al. Statins’ Regulation of the Virulence Factors of Helicobacter pylori and the Production of ROS May Inhibit the Development of Gastric Cancer[J].Antioxidants, 2021, 10(8): 1293.
[31]Kwon TJ, Kim TJ, Lee H, et al. Statin use decreases the risk of metachronous gastric cancer in patients without Helicobacter pylori infection[J]. Cancers, 2021, 13(5): 1020.
[32]Caldas M, Pérez-Aisa , Tepes B, et al. The role of statins on helicobacter pylori eradication: Results from the european registry on the management of h. pylori (hp-eureg)[J].Antibiotics, 2021, 10(8): 965.
[33]Cheung KS, Chan EW, Wong AYS, et al. Statins were associated with areduced gastric cancer risk in patients with eradicated Helicobacter pylori infection: a territory-wide propensity score matched study[J]. Cancer Epidemiol Biomarkers Prev, 2020, 29(2): 493-499.
[34]Park Y, Kim TJ, Lee H, et al. Eradication of Helicobacter pylori infection decreases risk for dyslipidemia: A cohort study[J]. Helicobacter, 2021, 26(2): e12783.

相似文献/References:

[1]张 强,胡炳炎,高 翔,等.综合干预对军队老干部血脂影响的观察[J].医学研究与战创伤救治(原医学研究生学报),2013,15(03):292.[doi:10.3969/j.issn.1672-271X.2013.03.028]
[2]王晨光,傅芬兰,张鹏程,等.全胃切除术后早期肠内外营养的临床研究[J].医学研究与战创伤救治(原医学研究生学报),2013,15(01):30.
　WANG Chen-guang,FU Fen-lan,ZHANG Peng-chen,et al.Evaluation of early parenteral nutrition and enteral nutrition in totalgastrectomy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(5):30.
[3]杜振双,张诚华.BillrothⅡ式胃切除术对患者血糖的影响[J].医学研究与战创伤救治(原医学研究生学报),2013,15(01):62.
[4]王 颖,钟 勇,史兆荣,等.中青年非酒精性脂肪肝与代谢综合征的关系[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):144.
[5]林夏雯,李爱梅,施 鸣,等.部分胃癌PET-CT显像与HIF-1α等指标的相关分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):407.
　LIN Xia-wen,LI Ai-mei,SHI Ming,et al.Analysis of relationship among HIF-1α,COX-2,VEGF and SUVmax in gastric cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(5):407.
[6]房文铮,陈锦华,欧阳学农.香菇多糖腹腔灌注联合热化疗治疗进展期胃癌[J].医学研究与战创伤救治(原医学研究生学报),2010,12(02):148.
[7]赵海滨,张伟杰,周志华,等.MMP-7、MMP-9、VEGF-C、VEGF-D在胃癌中的表达及其临床意义[J].医学研究与战创伤救治(原医学研究生学报),2010,12(03):197.
　ZHAO Hai-bin,ZHANG Wei-jie,ZHOU Zhi-Hua,et al.Expression and significance of MMP-7, MMP-9, VEGF-C, and VEGF-D in gastric carcinomas[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(5):197.
[8]徐桂芳,张建东,赵海滨,等.E-钙粘蛋白和MMP-9在胃癌组织中的表达及其临床意义[J].医学研究与战创伤救治(原医学研究生学报),2010,12(04):308.
　XU Gui-fang,ZHANG Jian-dong,ZHAO Hai-bin,et al.Expression and significance of E-Cadherin and matrix metalloproteinase-9 in gastric carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(5):308.
[9]仇学明,杜云翔,罗红来,等.ZnPPⅨ对胃癌腹膜转移细胞凋亡的影响[J].医学研究与战创伤救治(原医学研究生学报),2009,11(06):495.
　QIU Xue-ming,DU Yun-Xiang,LUO Hong-lai,et al.Effect of ZnPPⅨ on apoptosis of human gastric cancer cell line with peritoneal metastasis[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(5):495.
[10]徐 萍,唐永明.端粒酶活性在胃癌组织中表达的临床意义[J].医学研究与战创伤救治(原医学研究生学报),2009,11(06):518.
　XU Ping,TANG Yong-ming.The clinical significance of expression of telomerase in gastric cancer[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(5):518.

备注/Memo

备注/Memo:
基金项目：国家自然科学基金（81960430）
更新日期/Last Update: 2022-11-16